36% growth proven; margin expansion story just got hedged
Speedex delivered strong organic numbers in H1—36% revenue growth and 19.2% EBITDA margin, up 200 bps. But management's forward guidance contradicts itself: claiming margin sustainability while later admitting margins will stay flat as OEM scales. Execution risk on fuzzy guidance clouds what should be a bullish print.
₹78.5 Cr
+36% YoY
₹15.1 Cr
+52% YoY
19.2%
+200 bps YoY
₹9.9 Cr
~12.5% net margin
Speedex posted a strong H1 FY27: revenue of ₹78.5 crore (+36% YoY) and EBITDA of ₹15.1 crore (+52% YoY), with EBITDA margin expanding to 19.2% from 17.2%. The company also repaid ₹22.7 crore in short-term borrowings, bringing debt-to-equity down to 0.04. On paper, this is a clean quarter—organic growth, margin uplift, capital discipline. But the earnings call reveals a more complicated story: near-term roadmap is vague, and management's own statements contradict each other on what margins will do next.
The margin expansion claim — then the retreat
Management opened the call claiming margin expansion to 19.2% as a structural benefit from shifting in-house manufacturing from 88% to 93.5%, adding 447 bps to gross margin. That number is solid. But when pressed directly on whether margins would expand further, CEO Akash Agarwal walked it back: "EBITDA margins will stay similar (not expand) due to economies of scale offsetting brand mix gains." The headline read as margin expansion. The reality is margins will stabilize at current levels. Investors who heard "expansion" in the headline left the call hearing "hold steady."
EBITDA grew 52% to ₹15.1 crore
SupportedConfirmed: EBITDA ₹15.1 Cr, margin 19.2% (up from 17.2%). Gross margin gain of 447 bps from in-house manufacturing shift (88% → 93.5%) drove the uplift.
50% revenue growth expected going forward
OverstatedH1 delivered 36% growth. Management guidance: 'at least 50%' but hedged as 'ballpark figures, could be 40 to 45%.' No FY27 or FY28 specific target given.
New capacity will drive ₹23–24 crore monthly revenue
OverstatedCurrent monthly run-rate ₹16 Cr. New capacity at 72 lakh units. Path to 103 lakh by March 2027 takes 4–5 months post-February ramp to reach 85–90% efficiency. Potential stated but timeline vague.
Margins sustainable at 19–20% EBITDA
ContradictedH1 delivered 19.2%. Later clarification: margins will stay similar (not expand further) as OEM scaling offsets brand mix gains. Caps upside narrative.
What changed on this call
Capacity ramp: 62 lakh units → 72 lakh now, targeting 103 lakh by March 2027 (IPO-backed expansion)
Brand mix shift: own brand 14.5% of revenue, targeting 20–22% by EOY and 30% by next year; OEM 54–55% of mix
In-house manufacturing jumped 88% → 93.5%; gross margin up 447 bps
Online channel scaling: 14.5% of revenue now, targeting 20–22% by EOY via Amazon, Flipkart, Blinkit
Distributor network: 100 currently, targeting 150+ by year-end; expanded to 17 states, Tier 2/3 city focus
Debt paydown: ₹22.7 crore short-term borrowings repaid; debt/equity now 0.04
The bull-bear ledger
Strong organic H1: 36% revenue, 19.2% margin (+200 bps), driven by manufacturing shift and product mix
Capacity scaling backed by IPO proceeds; execution track record: 62 → 72 lakhs in H1
Structural market tailwinds: BIS quality norms and anti-dumping duties on Chinese imports (+20–25% cost premium), supply shortage favors organized players
Revenue diversification: online 14.5% and growing; no customer >11%; 50+ OEM/ODM counterparts; distributor network expanding
Margin expansion story contradicted: will stay flat at 19–20%, not expand, as OEM scales
Guidance vagueness: 50%+ growth as 'ballpark, could be 40–45%'; no FY27 or FY28 numeric targets; raises credibility risk
Working capital contradiction: stated '100% growth needs 100% funding' then 'don't see further requirement'
Competitive response emerging: Cello, Borosil adding capacity; if demand doesn't absorb new supply, margin/volume pressure likely
Ranked risks
Guidance vagueness and execution credibility
High50%+ revenue, 10% market share in 6 years, and 19–20% margin targets lack quantified FY27/FY28 roadmap. 'Ballpark' language on a first call post-IPO raises doubt about how committed or confident management is. Hedging this early is a red flag for execution risk.
Margin expansion narrative collapse
MediumOpening headline of margin uplift was undercut by later clarity that margins will hold steady (not expand further) as OEM scales. Suggests either unclear thinking or deliberate obfuscation. Damages the margin expansion bull thesis.
Competitive capacity additions
MediumCello and Borosil have added capacity. Currently market is supply-constrained (BIS/anti-dumping duties), but that tailwind is cyclical. If competitors absorb some supply constraint, Speedex faces margin and volume pressure.
Capacity ramp execution
MediumNew capacity lines take 4–5 months post-February to reach 85–90% efficiency. Any delay (machinery, labor, tech transfer) pushes 103-lakh target into Q4 FY27 or later. H1 ramp (62 → 72) was smooth; scaling to 103 is more ambitious.
Working capital surge if 50% growth sustained
Low–MediumManagement contradicted itself: '100% growth needs 100% funding' then 'don't see further requirement.' Current working capital <90 days (debtor 45–55, creditor 55–65 days). If growth accelerates or cycles lengthen, cash tightens.
How the street is positioned
At ₹268 (as of Nov 16), Speedex trades 6.78% below its all-time high (₹287.5) and 18.74% above its 52-week low (₹225.7). The stock is in the upper half of its 52-week range but has given back post-IPO highs. RSI of 57.1 is neutral (neither overbought nor oversold). Ownership is heavily skewed: promoters 63.93%, DII 11.70%, FII just 0.62%. The minimal foreign institutional stake suggests either late discovery or caution on near-term guidance and execution risk. Volume trend is normal—no panic or accumulation evident.
The price action tells the story: the market is holding the stock, not aggressively bidding it up after the call. That aligns with the fundamental read—strong H1 organic delivery deserves credit, but vague guidance and the margin hedge don't justify fresh highs. The fact that promoters own 64% and are staying committed (no block sales disclosed) is a positive insider signal. But FII sitting at <1% suggests global money is still on the sidelines—waiting for management to clarify the 50%+ growth and margin roadmap.
1 · February 2027 capacity ramp
New lines start production. Track whether they hit 85–90% efficiency within the stated 2-month window. Any delays push 103-lakh capacity target into Q4, raising execution risk on the full-year roadmap.
2 · Q3 FY27 revenue, margin, and distribution progress
Does online reach 20–22% by EOY? Do distributors hit 150+ by March? Compare against the 'ballpark' 40–50% growth management hedged. If Q3 shows 35%+ growth with stable margin, the vague guidance gains credibility. If growth slows to 25%+, the 50% target looks at risk.
3 · Margin trajectory and OEM/brand mix
Management said margins will hold at 19–20% as OEM scales. Watch whether gross margin continues to expand (in-house target ~95%) or plateaus. If brand mix shift drives margin UP and OEM pull-down balances it, margins defend 19–20%. If OEM demand surges and pulls mix down faster than brand uplift, margins compress.
Speedex's H1 was solid—36% growth, 19.2% EBITDA margin, and disciplined capex. The company has structural tailwinds (BIS, anti-dumping) and is executing on capacity scaling. But this is a steady quarter, not a step-change. The margin expansion story got hedged, the guidance is vague, and competitive response is emerging. Hold on the merit of strong execution and market tailwinds, but don't chase until the company quantifies its FY27–FY28 roadmap with specific revenue and margin targets. The metric to track: monthly revenue run-rate and EBITDA margin. If monthly revenue hits ₹18–19 crore by Q4 (vs. ₹16 crore now) and margins hold at 19.2%, the 50%+ growth call gains credibility. If both stall, the fuzzy guidance becomes a burden.
36% revenue surge, margin gains; execution risk on fuzzy guidance
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 7/10
Grade B
First earnings call post-IPO; H1 beat on delivery. No prior guidance to track. Management hit margin expansion and debt paydown.
Optimistic
next 1–2 quarters
Optimistic
multi-year
Speedex delivered a strong H1 (36% revenue, 19.2% EBITDA margin, debt reduction) on the back of BIS/anti-dumping tailwinds and product expansion. However, forward guidance is hedged—50%+ revenue growth and 10% market-share-in-6-years aspirations lack quantified FY27/FY28 targets or margin-expansion detail. Near-term capacity ramp (103 lakh by March 2027) is execution-dependent; Cello and Borosil competitive response is a material risk.
₹78.5 Cr
Revenue · +36% YoY₹9.9 Cr
Reported PAT · +null% YoYExpanding
Margins · vs guidance: UnverifiedDid the claims hold up?
EBITDA grew 52% to ₹15.1 crore
METEBITDA: ₹15.1 crore, margin 19.2% (up from 17.2%)
50% revenue growth expected going forward
OVERSTATEDH1 delivered 36% growth; guidance is 'at least 50%' but hedged as 'ballpark'
New capacity will drive ₹23-24 crore monthly revenue
OVERSTATEDCurrent monthly run-rate ₹16 crores; potential stated but timeline vague (ramps over 4-5 months post-Feb)
Margins sustainable at 19-20% EBITDA
MISSH1 delivered 19.2%; but management later stated margins will stay similar as OEM scales, not expand
Earnings quality
What changed since the last call
Capacity expansion accelerated
UpgradeIPO-funded expansion: 62 lakhs → 72 lakhs; next phase to 103 lakhs by March 2027. Prior: smaller single-line facility.
Brand mix shift initiated
UpgradeOwn brand online: 14.5% → target 20-22% by EOY. OEM/ODM ratio: 54-55% → target 65% own brand in 3-4 years. Prior: primarily OEM.
Margin story muddied
NeutralHeadline: 19.2% EBITDA (up 200 bps). But management clarified margins will stabilize at current levels, not expand further. Prior guidance: none.
The Q&A
Analysts pressed on capacity utilization, revenue visibility, and margin expansion. Management held firm on 50%+ growth and 19-20% EBITDA, but hedged specifics ('ballpark figures,' 'could be 40-45'). Confident on competitive moat but acknowledged Cello/Borosil risk. No significant retreats.
Capacity utilization — Piyush Bangar, Vijit Global Securities
AnsweredInitially 40-45 lakhs; ramped to 72 lakhs; takes 2 months to 85-90% efficiency. New lines: ₹23-24 crore monthly revenue potential. Peak: 30-40% above current, requiring ₹20-25 crore capex.
Market share and competitive positioning — Anil Shenoy, Individual Investor
Answered2% → 10% in 6 years. Competitors (legacy brands) limited to 20-25 SKUs. Speedex has 5 design patents. BIS duties and supply shortage favor Speedex. Capex: ₹20-25 crore for peak capacity; scaling over 4-5 months post-February.
Revenue growth and margin guidance — Nishita, Sapphire Capital
PartialCapacity growth 40%, revenue 50% (at least). Margins sustainable around 19-20% with economies of scale. Online business: 14.5% → target 30% in 2-3 years.
Segment profit breakdown — Aadi Menon, Abakkus Asset Management
AnsweredH1 split: 18% OEM, 20% distributor, 21% online. Target online 20-22% by EOY, 30% by next year. 100 distributors → 150+ by year-end. Revenue drivers: Amazon, Flipkart, Blinkit.
Employee cost escalation — Vipul Shah, Individual Investor
PartialCost increase due to hiring good team. Will stabilize ~0.5% higher (around 20-22% with scale). No seasonality mentioned; H1 benefited from school season.
Capacity timeline and margin expansion — Paryan Sharma, Individual Investor
AnsweredOnce reach 85-90%, new lines take 4-5 months. EBITDA margins will stay similar (not expand) due to economies of scale offsetting brand mix gains. 20-21% sustainable as own brand grows.
Revenue visibility and geographic expansion — Tanmay, Pace Group
Partial23-24 crore monthly from full 103-lakh capacity. Working capital: <90 days expected. Capex: 100% growth needs 100% funding, but no incremental requirement seen. Currently 17 states; expanding Tier 2/3 cities.
Customer concentration and ODM capabilities — Abhishek, Individual Investor
PartialNo customer >10-11%; split across 50+ OEM/ODM players. Can design 35-40k pieces monthly for economies of scale. Wallet share: ₹100 → ₹4-6 trajectory. 50% legacy brands, 50% online—both scaling.
Guidance
50%+ revenue growth expected (ballpark 40-50%)
MediumFull-year FY27 not specified. Based on new capacity ramp (103 lakh units by March) and online expansion (14.5% → 20-22%). Conditional on execution.
23-24 crore monthly revenue from full capacity utilization
MediumOne-time statement in Q&A; not a formal target. Implies ₹276-288 Cr annualized at peak (requires 85-90% utilization).
10% market share in 6 years (from 2%)
LowAspirational long-term vision; no connected FY revenue targets. CAGR implied ~40%+. Market supply-constrained due to BIS/anti-dumping duties.
EBITDA 19-20% sustainable
MediumH1 delivered 19.2%. Management clarified: will stay at current levels, NOT expand further, due to OEM growth offsetting brand mix gains. 2.5-3% incremental marketing spend for brand building.
Gross margin improvement through in-house manufacturing shift
High88% → 93.5% in-house in H1 added 447 bps gross margin. Further upside capped; full in-house target ~95% (diminishing returns).
20-25 crore capex for peak capacity (30-40% above current 72 lakh units)
MediumNew lines take 4-5 months to reach 85-90% efficiency. 103-lakh capacity by March 2027 funded via IPO proceeds already committed.
Risks the call surfaced
Competitive capacity response
MediumCello and Borosil have added manufacturing capacity. If demand does not grow proportionally, margin/volume squeeze likely. Market is supply-constrained now but that could shift.
Customer concentration risk
LowNo single customer >10-11% revenue. 50+ OEM/ODM players spread across legacy and online. Largest customers ask for 30-40% supply; Speedex caps at 10-11% policy.
Capacity ramp execution
MediumNew capacity lines take 4-5 months to reach 85-90% efficiency after February 2027 start. Any delay (machinery, tech transfer, labor) could push 103-lakh target into Q4 FY27 or later.
Guidance vagueness
Medium50%+ revenue growth, 19-20% margins, and 10% market share in 6 years are stated in 'ballpark' or aspirational terms. No quantified FY27/FY28 revenue, margin, or capex roadmap disclosed.
Working capital surge risk
MediumIf 50% revenue growth sustained, working capital needs could spike. Management stated '100% growth needs 100% additional funding' but then hedged 'don't see further requirement.' Contradiction suggests uncertainty.
Management
Score 7/10. Detailed on market dynamics and competitive positioning; hedged on specific metrics ('ballpark figures,' 'difficult to tell exact number'). Provided segment breakdowns and explained margin drivers. Avoided over-commitment but sometimes unclear. H1 delivery strong: 36% revenue growth, 19.2% EBITDA margin (+200 bps), ₹22.7 Cr debt paydown, capacity scaled 62 → 72 lakhs. This is the first full quarter post-IPO; track record builds credibility.
1 · Feb 2027
New capacity lines ramp; two-month lag to 85-90% efficiency
2 · Mar 2027
103 lakh units annual capacity operational; online channel 20-22%
3 · Mar 2028
150+ distributors; online 30%; brand mix 65% own brand target
Near-term capacity ramp (103 lakh by March 2027) is execution-dependent; Cello and Borosil competitive response is a material risk.